Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.52
-0.025-1.61%
Last update: Oct 22, 2:48 PM
$1.55
N/A
InflaRx NV (IFRX) Stock Price, Quote, News & History
IFRXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of InflaRx (NASDAQ:IFRX) through any online brokerage.
Other companies in InflaRx’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
InflaRx has a consensus price target of $8.70.
The stock price for InflaRx (NASDAQ: IFRX) is $1.525 last updated October 22, 2026 at 2:48 PM EDT.
There are no upcoming dividends for InflaRx.
InflaRx does not have any upcoming earnings scheduled.
There is no upcoming split for InflaRx.
InflaRx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
